We've merged Palleos Healthcare to form a wide-reaching European CRO.
Find out more
In this episode, we will be discussing one of the major breakthroughs of the decade in the field of healthcare technology: Real-World Evidence and Real-World Data. Our guest will share his thoughts and first-hand insights on how big data is going to transform the pharmaceutical research within the next 5 to 10 years. Please meet, Alex Loleit, Chief Strategy and Product Officer at DM RWE.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
